Showing 2640 results
- Media Release /Basel, January 4, 2022 — Today, Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) issued its decision upholding the validity of US Patent No. 9,187,405 covering a…
- Statement /
- Story /
- Featured News /
Latest resources and news surrounding Novartis data featured at the 63nd American Society of Hematology Annual Meeting (ASH).
- Featured News /
Novartis Chief Digital Officer, Bertrand Bodson, and Microsoft Corporate Vice President Research & Incubation, Peter Lee, discussed why healthcare’s digital moment is now.
- Key Release /Ad hoc announcement pursuant to Art. 53 LR FDA also approved complementary diagnostic imaging agent, Locametz®, after radiolabeling with gallium-68 for the identification of PSMA-positive…
- Statement /
- Media Release /CHMP opinion based on Phase III REACH2 and REACH3 trials that showed Jakavi improved response rates and failure-free survival compared to best available therapy1,2 Graft-versus-host disease (GvHD)…
Pagination
- ‹ Previous page
- 1
- …
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- …
- 264
- › Next page